As shown in Fig. 5b, silencing efficiently reduced the survivin protein which at functional level led to sensitization of MM cells to BTZ in the presence of BMSCs partially overcoming stroma-mediated drug resistance. The gene discussed is CASC3; the disease is Miyoshi myopathy.